France's Macron wins comfortable majority, but abstention at record-high

Alexander Bueso Sharecast | 19 Jun, 2017 07:09 - Updated: 09:01 | | |

cbmacron26

French president Emmanuele Macron's upstart centrist movement and his allies won a comfortable majority in legislative elections at the weekend, albeit amid a record low turnout, a stark reminder that a large minority of French are opposed to his plans.

Macron's En Marche! and his centre-right allies from MoDem made off with about 360 seats in the country's parliament.

Although less than the 400 seats that some polls had projected, he was still set to enjoy a comfortable majority of about 70 seats.

At 43.4%, turnout was the lowest ever, seven percentage points less than in the first round and 10 percentage points less than the previous record low.

Next on the agenda for Macron would be to confirm his government and announce his general policy intentions ahead of a confidence vote on 4 July.

Perhaps most significantly for financial markets, his labour market reform was expected to be fast-tracked and endorsed before the end of September.

The centre-right coalition between Les Republicains and the Union of Democrats and Independents lost 100 seats in Sunday's vote and was left with only 131 MPs.

Nonetheless, it was the Socialists which fared worst, surrendering nearly 250 seats and left with just 44.

France's radical left, in the form of France Insoumise and Communists managed to increase their representation, from 15 seats to 28 as did the far-right Front National which gained six seats to reach eight.

More news

08:08 Rathbone Brothers funds under management rise in third quarter

FTSE 250 wealth manager Rathbone Brothers reported a jump in assets in the third quarter on Wednesday as inflows grew.

07:51 Rio Tinto slapped with £27m fine, Reckitt Benckiser endures 'soft' quarter

London open

07:46 Spectris completes acquisition of Omnicon

Spectris has completed the acquisition of privately-held US company The Omnicon Group, for an initial consideration of $29m.

07:41 London pre-open: Stocks seen higher ahead of unemployment, wages data

London stocks were set for a positive open on Wednesday as investors eyed the release of the latest UK wages and unemployment data.

07:39 AstraZeneca granted priority review from FDA for Lynparza in metastatic breast cancer

AstraZeneca said on Wednesday that it and Merck & Co have been granted priority review by the US Food and Drug Administration for a supplemental new drug application for the use of Lynparza (olaparib) tablets in patients with metastatic breast cancer who have been previously treated with chemotherapy.

07:26 Rio Tinto settles with FCA over Mozambique impairment, faces US fraud claims

Rio Tinto was slapped with a £27.4m fine by the City watchdog for failings in its financial reporting process relating to the $3.7bn purchase of mining assets in Mozambique, an issue that US regulators have also now begun to investigate.

07:25 Wednesday newspaper round-up: Sainsbury's, Rio Tinto, Monarch

Sainsbury’s is axing 2,000 store and back office roles as the supermarket chain looks to slash costs by £500m amid an intensifying price war with Aldi and Lidl. The retailer is restructuring its HR departments, getting rid of 1,400 store-based clerks and another 600 staff based in the back offices that serve the chain as well as Argos and Sainsbury’s bank. - Guardian

17 Oct US close: Markets finish higher amid busy earnings season

US markets finished in the green on Tuesday, with the Dow closing just short of the 23,000 mark which it breached for the first time ever earlier in the session, amid a busy third quarter earnings season on Wall Street.

17 Oct Europe close: Stocks slip ahead of US Fed Beige Book

Stocks on the Continent finished slightly lower as investors bid their time ahead of the release of the US central bank's Beige Book on Wednesday, against the backdrop of fresh intra-day records on Wall Street's main benchmarks with the Dow Industrials having climbed above the 23,000 point mark for the first time ever.

17 Oct Buy Spain as political risk is 'overstated' - Credit Suisse

Spanish equities look unusually cheap, said Credit Suisse on Tuesday, as political risk is "overstated" and the country is on track for at least 3% growth, with employment, housing and construction all on a growth tear.